Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
<h4>Objective:</h4> <p>To investigate the association between neuromyelitis optica spectrum disorder (NMOSD) and pregnancy outcome.</p> <h4>Methods:</h4> <p>An international cohort of women with aquaporin-4 antibody–positive NMOSD and $1 pregnancy was studie...
Main Authors: | Nour, M, Nakashima, I, Coutinho, M, Woodhall, M, Sousa, F, Revis, J, Takai, Y, George, J, Kitley, J, Santos, M, Nour, J, Cheng, F, Kuroda, H, Misu, T, Martins-da-Silva, A, DeLuca, G, Vincent, A, Palace, J, Waters, P, Fujihara, K, Leite, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Academy of Neurology
2015
|
Similar Items
-
PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
by: Nour, M, et al.
Published: (2014) -
The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
by: Nour, M, et al.
Published: (2014) -
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
by: Kitley, J, et al.
Published: (2013) -
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
by: Kitley, J, et al.
Published: (2013) -
Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
by: Kitley, J, et al.
Published: (2013)